Tirzepatide, known under the brand name Mounjaro is prescribed for type 2 diabetes, but has been shown in clinical trials to ...

In one hand, a slender young woman holds up a bottle of clear liquid. The words “Skinny” and “GLP-1” — a new class of weight loss drugs — are visible on the label. In the other hand, she raises up a ...

Bollywood actor Arjun Kapoor, who is now in the spotlight for his performance in his latest film Singham Again, has stated ...

Donald Trump’s win challenges the state’s progressive policies on climate, immigration, abortion and LGBTQ rights. Meanwhile, ...

Sweden has blocked more than a dozen offshore wind farms in the Baltic Sea over fears they could make the country more ...

In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...

Al Roker opened up about food addiction and the use of trendy weight loss medications, admitting that he won’t judge those ...

AstraZeneca and Viking Therapeutics both presented encouraging data on their obesity pills. Meanwhile, here’s how Americans ...

AstraZeneca PLC shed £15 billion of market capitalization on Tuesday, after investors were underwhelmed by early data from a trial of a weight-loss pill. The company UK:AZN said its lead product ...

though the total remaining loss was not disclosed. Distribution revenue for Q3 was $719 million, up 20% year over year. Ad sales were $622 million for the quarter with “other” revenues at $25 ...